Micro RNAs to Predict Response to Androgen Deprivation Therapy

NCT02366494 · clinicaltrials.gov ↗

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Bicalutamide
DRUG: Leuprolide
DRUG: Goserelin
DRUG: Triptorelin
DRUG: Docetaxel
DRUG: Abiraterone
DRUG: Apalutamide
DRUG: Enzalutamide

Sponsor

Medical College of Wisconsin